print ISSN: 2411-3956
New approaches in the treatment and prfoilaxis of osteoporosis
##common.pageHeaderLogo.altText## Actual Questions of Modern Gynecology and Perinatology

Abstract

Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone pro­ duction. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treat­ ments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-phar­ macological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoreti­ cal basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteopo­ rosis, including the development of new strategies.

 

 

References

Agustin Aibar-Almazan, Ana Voltes-Martinez,Yolanda Castellote-Caballero et al. Current Status of the Diagnosis and Management of Osteoporosis. Int J Mol Sci. 2022 Aug; 23(16): 9465. Published online 2022 Aug 21. doi: 10.3390/ijms23169465. PMCID: PMC9408932/ PMID: 36012730

Genant H.K., Cooper C., Poor G., Reid I., Ehrlich G., Kanis J., Nordin B.E., Barrett-Connor E., Black D., Bonjour J.P., et al. Interim report and recommendations of the World Health Organization Task­ Force for Osteoporosis. Osteoporos. Int. 1999;10:259-264. doi: 10.1007/s001980050224. [PubMed]

Letarouilly J.G., Broux 0., Clabaut A. New insights into the epigenetics of osteoporosis. Genomics. 2019;111:793-798.

Peris P., Martinez-Ferrer A., Monegal A., Martinez de Osaba M.J., Alvarez L., Ros I., Muxi A., Reyes R., Guafiabens N. Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clin. Exp. Rheumatol. 2008;26:582-588. [PubMed] [Google Scholar]

Sozen T., Oz1 1k L., Ba aran N. An overview and management of osteoporosis. Eur. J. Rheumatol. 2017;4:46-56. doi: 10.5152/eurjrheum.2016.048.

Gonzalez Jimenez E., Alvarez Ferre J., Pozo Cano M.D., Navarro Jimenez M.C., Aguilar Cordero M.J., Tristan Fernandez J.M. Osteoporosis involutiva tipo I en la mujer posmenopausica: Diagn6stico y manejo clinico. REEMO. 2009;18:77-84. doi: 10.1016/S1132-8460(09)73462-2.

Cosman F., de Beur S.J., LeBoff M.S., Lewiecki E.M., Tanner B., Randall S., Lindsay R. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos. Int. 2014;25:2359-2381. doi: 10.1007/s00198-014-2794-2.

Weaver C.M., Alexander D.D., Boushey C.J., Dawson-Hughes B., Lappe J.M., LeBoff M.S., Liu S., Looker A.C., Wallace T.C., Wang D.D. Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation. Osteoporos. Int. 2016;27:367-376. doi: 10.1007/s00198-015-3386-5.

Bauer D.C. Calcium supplements and fracture prevention. N. Engl. J. Med. 2014;370:387-388. doi: 10.1056/NEJMcp1210380.

PDF (Azərbaycanca)
PDF (Azərbaycanca)

Keywords

osteoporosis, treatment, regenerative medicine, cell therapies, prophilaxis, lifestyle habits osteopeniya, osteoporoz, menopauza, miialica, profilaktika остеопороз, лечение, регенеративная медицина, клеточная терапия, профилактика, образ жизни